The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Ruizhi Qin - JPMorgan Chase & Co, Research Division - Analyst
: Great. Thank you, Shawn. That was a great overview. And as you accurately predicted, I'm going to start by asking the most asked question about
CEO transition. So can you talk a little bit about the background, how long has this been planned for? And why is now the right time? And looking
forward, what can we expect in terms of any continuation or any changes in the strategy going forward?
Question: Ruizhi Qin - JPMorgan Chase & Co, Research Division - Analyst
: That's great. Turning to COVID tailwind, are you able to break out how much a tailwind have you seen on the testing side versus the vaccine and
therapeutic side? And given the resurgence in cases in recent months, how much testing tailwind have you seen in 4Q and what's your expectations
for 2021?
Question: Ruizhi Qin - JPMorgan Chase & Co, Research Division - Analyst
: Got it. Can you talk about the latest recovery trends across the different end markets for your base business?
Question: Ruizhi Qin - JPMorgan Chase & Co, Research Division - Analyst
: Got it. That makes sense. Maybe in the last remaining minute, a final question. What percentage of your portfolio will benefit from increased demand
in a post-COVID work regime, such as lab automation? And what about incremental opportunities for you on the service side?
Question: Ruizhi Qin - JPMorgan Chase & Co, Research Division - Analyst
: All right. Well, that's all the time we have. Thank you so much, Shawn, for a great overview and good luck with the rest of the conference, and I look
forward to talking again soon.
Question: Ruizhi Qin - JPMorgan Chase & Co, Research Division - Analyst
: Take care. Goodbye.
DISCLAIMER
Refinitiv reserves the right to make changes to documents, content, or other information on this web site without obligation to notify any person of such changes.
In the conference calls upon which Event Transcripts are based, companies may make projections or other forward-looking statements regarding a variety of items. Such forward-looking statements are based upon
current expectations and involve risks and uncertainties. Actual results may differ materially from those stated in any forward-looking statement based on a number of important factors and risks, which are more
specifically identified in the companies' most recent SEC filings. Although the companies may indicate and believe that the assumptions underlying the forward-looking statements are reasonable, any of the
assumptions could prove inaccurate or incorrect and, therefore, there can be no assurance that the results contemplated in the forward-looking statements will be realized.
THE INFORMATION CONTAINED IN EVENT TRANSCRIPTS IS A TEXTUAL REPRESENTATION OF THE APPLICABLE COMPANY'S CONFERENCE CALL AND WHILE EFFORTS ARE MADE TO PROVIDE AN ACCURATE TRANSCRIPTION,
THERE MAY BE MATERIAL ERRORS, OMISSIONS, OR INACCURACIES IN THE REPORTING OF THE SUBSTANCE OF THE CONFERENCE CALLS. IN NO WAY DOES REFINITIV OR THE APPLICABLE COMPANY ASSUME ANY
RESPONSIBILITY FOR ANY INVESTMENT OR OTHER DECISIONS MADE BASED UPON THE INFORMATION PROVIDED ON THIS WEB SITE OR IN ANY EVENT TRANSCRIPT. USERS ARE ADVISED TO REVIEW THE APPLICABLE
COMPANY'S CONFERENCE CALL ITSELF AND THE APPLICABLE COMPANY'S SEC FILINGS BEFORE MAKING ANY INVESTMENT OR OTHER DECISIONS.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
|
